Bhubaneswar: A day ahead of polling in Kendrapara Lok Sabha constituency, the BJD and the BJP on Sunday engaged in a blame game, accusing each other of violating the model code of conduct.
The BJD filed a petition with Chief Electoral Officer (CEO) Surendra Kumar, demanding immediate action against Jyoti Ghosh, election agent and a close associate of BJP MP candidate Baijayant Panda, and regional news channel OTV (owned by Panda’s family) for allegedly spreading false news against its MP candidate Anubhav Mohanty with an intention to defame him.
The BJP, in turn, alleged that several BJD leaders hailing from outside Kendrapara constituency were camping and distributing illicit cash to gain over the voters. The poll code stipulates that those who are not voters should leave the constituency 48 hours before polling but several BJD ministers, MLAs and youth activists are contravening the provisions, it said and demanded the CEO to oust them from the constituency.
On Saturday, the BJD wrote to the CEO alleging “distribution of cash among voters” by four associates of Baijayant. The party has asked the Election Commission to take “strict and immediate” action. It suggested placing the four associates and their cellphones under surveillance or even removing them from Kendrapara Lok Sabha constituency.
New Delhi: Delhi and Mumbai, two of the fastest-growing cities in India, have now made…
Puri: Jagannath Temple in Odisha’s Puri will remain out of bounds for devotees for six…
Bhubaneswar: Neeraj Chopra will be competing in India after a long time. He will be…
Cuttcak: Actor-turned-politician Anubhav Mohanty again found himself in a soup after the JFMC court here…
New Delhi: The management of a leading school in Mumbai on Tuesday announced it has…
New Delhi: The Central Bureau of Investigation (CBI) on Tuesday said that it has arrested…
Bhubaneswar: Defence Minister Rajnath Singh will address Vijay Sankalp rallies in Bhawanipatna and Rayagada on…
New Delhi: After admitting that its COVID-19 vaccine can cause rare side effects, AstraZeneca has…